6/11付の米国FDAによるCOVID-19絡みガイダンス等の発出について、筆者のお好みでお伝えします。
関係者および興味のある方は、下記URLsのNews Release等をご参照ください。
l6/11付Updated「Coronavirus Disease 2019 (COVID-19)」
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19
l6/11付Updated「Coronavirus (COVID-19) Update: Daily Roundup June 11, 2020」
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-june-11-2020
l6/11付News Release「FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord」
https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-rare-disease-affecting-optic-nerve-spinal-cord
l6/11付FDA Voices「Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19」
https://www.fda.gov/news-events/fda-voices/rare-disease-therapy-development-and-access-remain-top-fda-priorities-during-covid-19
l6/11付Updated「Emergency Use Authorizations」
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
l6/10付Updated「FAQs on Diagnostic Testing for SARS-CoV-2」
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2
関係者および興味のある方は、下記URLsのNews Release等をご参照ください。
l6/11付Updated「Coronavirus Disease 2019 (COVID-19)」
https://www.fda.gov/emergency-
l6/11付Updated「Coronavirus (COVID-19) Update: Daily Roundup June 11, 2020」
https://www.fda.gov/news-
l6/11付News Release「FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord」
https://www.fda.gov/news-
l6/11付FDA Voices「Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19」
https://www.fda.gov/news-
l6/11付Updated「Emergency Use Authorizations」
https://www.fda.gov/medical-
l6/10付Updated「FAQs on Diagnostic Testing for SARS-CoV-2」
https://www.fda.gov/medical-
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント